ANGELA ULLRICH: Open Payments
NPI 1952145096 · OSAGE BEACH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,915 in 105 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $876 · 2025 $1,915
Food & beverage: $1,915
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $342 |
| ABBVIE INC. | 13 | $245 |
| PFIZER INC. | 23 | $193 |
| Neurelis, Inc. | 4 | $120 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| UCB, Inc. | 4 | $87 |
| ANI Pharmaceuticals, Inc. | 4 | $86 |
| SK Life Science, Inc. | 3 | $63 |
| ACADIA Pharmaceuticals Inc | 3 | $63 |
| Boston Scientific Corporation | 2 | $59 |
Products named: NURTEC ODT, KESIMPTA, VALTOCO, UBRELVY, REXULTI, PURIFIED CORTROPHIN GEL, LUTATHERA, QULIPTA.
Industry payments across MO — which companies pay providers there.
